Treatments

Our treatments, and how each one works.

Six evidence-based options for treatment-resistant depression, OCD and complex mood disorders. For each one: who it is for, what a visit is like, what insurance usually covers, and a step-by-step 3D guide to how it works.

FDA-cleared for major depressive disorder, including with anxiety symptoms

TMS uses focused magnetic pulses to stimulate brain areas involved in mood regulation. You sit awake in a reclining chair; there is no anesthesia and no implanted device, and you can return to work or drive right after a session. We use the MagVenture TMS system.

Candidates are adults with major depression who have not improved enough with antidepressant medication in the current episode. Every course starts with a psychiatric evaluation, a medical screen and a safety review.

Session length
About 19 minutes for standard TMS; a few minutes for theta burst
Typical course
About 36 sessions: daily on weekdays for 6 weeks, then a 3-week taper, adjusted to you
After a session
Drive yourself and return to normal activities
Common side effects
Scalp discomfort, headache, facial twitching during pulses; usually mild
Coverage
Covered by most plans when criteria are met, including Medicare and Virginia Medicaid

Published results

37%

of patients reached remission and 58% responded to a TMS course in a naturalistic study of 307 patients treated in clinical practice. Carpenter et al., Depression and Anxiety, 2012

From a published study, not from our clinic. Individual results vary.

Request a consultation

FDA-approved for treatment-resistant depression and for depressive symptoms with acute suicidal thoughts or behavior

Esketamine is a nasal spray you take yourself in our REMS-certified clinic, under direct observation by our clinical team. It is never dispensed for use at home. You stay with us for at least two hours afterward while we monitor blood pressure, sedation and dissociation.

It is for adults with treatment-resistant depression (an inadequate response to at least two antidepressants) or with major depression and acute suicidal thoughts or behavior. Treatment requires a psychiatric evaluation, medical screening, REMS enrollment and insurance review.

Do not drive or operate machinery until the next day, after a restful sleep. Plan a ride home before each visit. Spravato Prescribing Information and Medication Guide.

Visit length
About 2 to 2½ hours, including at least 2 hours of monitoring
Typical course
Twice weekly for 4 weeks, weekly for 4 weeks, then weekly or every other week
After a visit
No driving until the next day, after a restful sleep
Common side effects
Dissociation, sedation, dizziness, nausea and temporary blood pressure rise
Coverage
Usually covered when REMS and plan criteria are met

Published results

69%

responded to esketamine plus a new antidepressant at four weeks, compared with 52% on an antidepressant plus placebo. Popova et al., TRANSFORM-2, American Journal of Psychiatry, 2019

From a published study, not from our clinic. Individual results vary.

Request a consultation

Off-label use for treatment-resistant depression

Ketamine is given by intravenous infusion (about 40 minutes) or intramuscular injection in our clinic, with a clinician monitoring you throughout. Dosing and schedule are set individually after your evaluation.

It is used for carefully selected patients with treatment-resistant depression who have not responded to other treatments. Evaluation includes medical screening, a substance use history and a safety assessment.

$400per treatment, self-pay. Ketamine is not usually covered by insurance.
Treatment
IV infusion (about 40 minutes) or IM injection, then monitored recovery
Schedule
Individualized after your evaluation
After a visit
You cannot drive yourself home; arrange a ride
Common side effects
Dissociation, sedation, nausea and temporary blood pressure changes

Request a consultation

FDA-cleared as an adjunct treatment for adults with OCD

We offer TMS for obsessive-compulsive disorder with the MagVenture Cool D-B80 coil, which is FDA-cleared as an adjunct treatment for adult OCD and stimulates the dorsomedial prefrontal cortex on both sides.

OCD TMS works alongside exposure and response prevention (ERP) therapy and medication; it does not replace them. It is for adults whose symptoms persist despite appropriate ERP and medication. Evaluation includes a Y-BOCS severity rating, a review of prior treatment and safety screening.

Treatment
Noninvasive, awake, no anesthesia or sedation
Typical course
Daily weekday sessions; length set at your evaluation
Works with
ERP therapy and medication, which continue
Coverage
Reviewed case by case with insurance coordination

Request a consultation

FDA-approved as an adjunctive long-term treatment for chronic or recurrent depression after four or more adequate antidepressant treatments

VNS uses a small implanted device to stimulate the vagus nerve. It is for adults 18 and older with chronic or recurrent depression who have not responded to four or more adequate antidepressant treatments.

We evaluate candidacy, coordinate with LivaNova on prior authorization and a neurosurgical partner, and follow you psychiatrically after implantation, including routine stimulator adjustments. The implant itself is placed by a neurosurgeon in a hospital, not at our clinic.

Where
Implanted by a neurosurgeon in a hospital; adjustments here
Timeline
Benefits build gradually over months
Coverage
Reviewed case by case; our team coordinates with insurers and LivaNova

Request a consultation

Comprehensive psychiatric care

Many people labeled treatment-resistant were never on the right dose for long enough, or have a condition that was missed. We start with a full review of your history, diagnosis and prior trials, then build a medication plan and track progress with standard rating scales.

Our geriatric psychiatry expertise is especially useful for older adults, where depression can overlap with memory problems, delirium, medication effects and other medical conditions.

What we review
Diagnosis, every prior medication trial, therapy history and medical factors
How we measure
PHQ-9, MADRS, GAD-7 and Y-BOCS
Who we see
Adults and older adults, including complex medical histories
Coverage
Covered by the plans we accept

Published results

1 in 3

people with major depression did not reach remission after four treatment steps in the largest real-world antidepressant study. Rush et al., STAR*D, American Journal of Psychiatry, 2006

From a published study, not from our clinic. Individual results vary.

Request a consultation

Choosing a treatment

Not sure which treatment is right?

You don't need to decide before you call. The right treatment depends on your diagnosis, prior treatment, medical safety and goals, and your evaluation sorts that out with you.

Coverage and costs for each treatment, and the plans we accept, are on the New patients page.

Patient guides

Understand depression, and how we treat it.

Short interactive guides in plain language, in six groups. Start anywhere.

See all the guides

These guides are for education only and are not medical advice. Our medical director reviews every guide.

Ready to take the next step?

Your first consultation is an evaluation, not a commitment to any treatment. Our patient advocate calls you back within one business day.

Or call us(571) 378-13986849 Old Dominion Drive, Suite 315, McLean

Read our reviews on Google

Call (571) 378-1398Request a consultation